Innova Captab Ltd

AGM Details

• AGM held on 30 September 2026 at 11:00 IST via VC/OAVM; concluded 11:30 IST.
• Remote e-voting from 27 to 29 September 2026; on-meeting voting for 30 minutes.
• Attendance: 49 members (44 via VC, 4 physically present).

Ordinary Resolutions

• Item 1: Adopt Audited Standalone and Consolidated Financial Statements for FY 2025-26.
• Item 2: Re-appoint Jayant Rao as Director by rotation.
• Item 3: Re-appoint M/s B S R & Co. LLP as Statutory Auditors.

Special Resolutions

• Item 4 (Ordinary): Ratify cost auditor remuneration for FY 2027.
• Item 5 (Ordinary): Re-appoint Manoj Lohariwala as WTD for five years.
• Item 6 (Ordinary): Re-appoint Vinay Lohariwala as MD for five years.
• Item 7 (Special): Re-appoint Sudhir Kumar Bassi as NED for second five-year term.
• Item 8 (Special): Re-appoint Priyanka Dixit as NED for second five-year term.
• Item 9 (Special): Re-appoint Mahendar Korthiwada as NED for second five-year term.
• Item 10 (Special): Re-appoint Shirish Gundopant Belapure as NED for second five-year term.

Dividend

• Dividend: No dividend proposed or declared.

Directors & Key Appointments

• Re-appointment of Jayant Rao (rotation).
• Re-appointment of Manoj Lohariwala as WTD; five-year term.
• Re-appointment of Vinay Lohariwala as MD; five-year term.
• Re-appointment of Sudhir Bassi as ID; second five-year term.
• Re-appointment of Priyanka Dixit as ID; second five-year term.
• Re-appointment of Mahendar Korthiwada as ID; second five-year term.
• Re-appointment of Shirish Belapure as ID; second five-year term.

Auditors

• Statutory Auditors: Re-appointment of M/s B S R & Co. LLP.

Voting Status

• Voting results: Combined e-voting and AGM results to be intimated to exchanges and uploaded.

Rating Action

• CARE upgraded Innova Captab Long-Term facilities to CARE A+, Stable outlook, from CARE A; Positive.

Facilities and Ratings

• Long-Term facilities ₹419.60 crore upgraded to CARE A+; Stable; from CARE A; Positive.
• Short-Term facilities ₹40.00 crore upgraded to CARE A1+; from CARE A1.

Outlook

• Long-Term outlook: Stable.

Rationale

• Based on FY26 audited and Q1FY27 unaudited operational and financial performance.

Material Changes

• Upgraded long-term from CARE A; Positive to CARE A+; Stable outlook.
• Upgraded short-term from CARE A1 to CARE A1+.

Facilities Summary

• Total facilities ₹459.60 crore.

Innova Captab Limited – Trading window closed from 01 October 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ending 30 September 2026.

Meeting Details

• Date/time: 21 September 2026, 10:00 IST; type: 1x1/group; mode: physical.
• Event: Anand Rathi Annual Flagship Conference G-200 Summit 2026; location: Mumbai.
• Company representative: Company Secretary & Compliance Officer to participate.

Participants

• Key company participant: Company Secretary & Compliance Officer.

Purpose

• Purpose: discussions will be based on publicly available information.

Land acquisition

• In-principle approval granted for land purchase; estimated investment ~₹50 crore; final purchase agreement to be executed.
• Details to be intimated to exchanges upon execution of final agreement.

AGM notice approval

• Board approved the notice calling the 22nd AGM for year ending March 31, 2026.
• Annual report and AGM notice will be submitted to stock exchanges in due course; earlier postponement acknowledged.

Financial results approved

• Revised Audited Standalone and Consolidated results for quarter and year ended 31 March 2026 approved.
• Auditors' report issued with unmodified opinion for both standalone and consolidated results.
• CFO declaration of unmodified opinion enclosed.
• Results to be hosted on company website for compliance.

Brownfield expansion

• Brownfield expansion of the Baddi facility approved within the same premises.
• Capex estimated at ₹45 crore; completion targeted in 18–22 months.
• Expansion financing planned via bank credit facilities and internal accruals.

Dividends and financing actions

• Interim dividend of ₹2 per equity share approved.
• Expansion financing to be sourced from a mix of bank credit facilities and internal accruals.